ImageneBio Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for ImageneBio stock has a target of 30, which predicts a 264.08% increase from the current stock price of 8.24.

Price Target: $30 (+264.08%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$30	$30	$30	$30
Change	+264.08%	+264.08%	+264.08%	+264.08%

Analyst Ratings

According to 1 stock analyst, the rating for ImageneBio is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25
Strong Buy	0
Buy	1
Hold	0
Sell	0
Strong Sell	0
Total	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Risinger Leerink Partners	Leerink Partners	Buy Initiates $30	Buy	Initiates	$30	+264.08%	Oct 24, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 3.50M

Revenue Next Year

n/a

EPS This Year

-5.82

from -0.12

EPS Next Year

-3.35

from -5.82

Fiscal Year	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	7.96M	3.50M	-	-	-	-	-
Revenue Growth	-	-56.04%	-	-	-	-	-
EPS	-0.10	-0.12	-5.82	-3.35	-6.18	-7.31	-5.46
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	3	2	2	2	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-6.05	-3.49
Avg	-5.82	-3.35
Low	-5.64	-3.25

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.